Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-29

FDA Approved: DEFERIPRONE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a generic version of deferiprone (ANDA 213239) from Hikma Pharmaceuticals USA Inc. under an original application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferiprone (deferiprone)

Snippet

ORIG AP for DEFERIPRONE (DEFERIPRONE)